Despite extensive research, the origins of COVID-19 remain elusive. In a new study published in the KeAi journal Advances in Biomarker Sciences and Technology (ABST), an AI-driven approach was adopted to examine DNA methylation patterns at 865,859 CpG sites in blood samples from early COVID-19 patients.
Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) – Biotech Investments
EQS-News: Epigenomics AG / Key word(s): Personnel Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) 26.01.2024 / 13:16 CET/CEST The issuer is solely responsible
January 27, 2024